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Background: Research on length of stay (LOS) of psychiatric inpatients is an under-investigated issue. In this
naturalistic study factors which affect LOS of two groups of patients were investigated, focusing on the impact on
LOS of medical comorbidity severe enough to require referral.
Methods: Active medical comorbidity was quantified using referral as the criterion. The study sample consisted of
200 inpatients with the diagnosis of schizophrenia and 228 inpatients suffering from bipolar disorder (type I or II).
Jonckheere and Mann–Whitney tests were used to estimate the influence of referrals on LOS, and regression
analyses isolated variables associated with LOS separately for each group.
Results: Half of the patients needed one or more referrals for a non-psychiatric problem. The most common
medical condition of patients with bipolar disorder was arterial hypertension. Inpatients with schizophrenia suffered
mostly from an endocrine/metabolic disease - 12% of referrals were for Hashimoto’s thyroiditis. A positive linear
trend was found between LOS and number of referrals; the effect was greater for schizophrenia patients. The effect
of referrals on LOS was verified by regression in both groups. Overall, referred patients showed greater
improvement in GAF compared to controls.
Conclusions: To our knowledge this was the first study to investigate physical comorbidity in psychiatric inpatients
using the criterion of referral to medical subspecialties. Comorbidity severe enough to warrant referral is a
significant determinant of hospital stay. This insight may prove useful in health care planning. The results show lack
of effective community care in the case of schizophrenia and negative symptoms may be the cause of this. Our
findings call for more attention to be paid to the general medical needs of inpatients with severe mental health
and concurrent severe medical comorbidity.
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Mental health patients often suffer from concurrent
medical conditions [1]. Rates of medical morbidity are
reported to be particularly high in certain groups of
patients. It has been estimated that more than half of
patients with schizophrenia suffer from a chronic med-
ical problem [2].There are reports of increased rates of
hypertension [3], hyperlipidemia, obesity and diabetes
[4,5]. Patients suffering from bipolar disorder also report
increased medical comorbidity [6] with asthma, chronic* Correspondence: thandouz@med.uoa.gr
1Second Psychiatry Department, Athens University Medical School, Attikon
General Hospital, 1 Rimini st, Athens 12462, Greece
Full list of author information is available at the end of the article
© 2012 Douzenis et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the orbronchitis, hypertension, and gastric ulcer [7] as well as
diabetes, coronary artery disease and dyslipidemia [8].
Instances of physical medical problems have been
associated with an increased burden on psychiatric
patients resulting in poorer outcomes for their psychi-
atric condition, greater severity of psychiatric symptoms
[9] as well as an increased incidence of non-compliance
with treatment. In this respect, the prompt identification
of comorbid physical problems for mental health
patients is a significant issue that might have a role in
improving subsequent outcomes, both medical and psy-
chiatric. Regarding inpatients there is an additional rea-
son for addressing physical problems. It has been
suggested that medical comorbidity increases the lengthal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Prevalence of physical conditions which needed referral
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http://www.biomedcentral.com/1472-6963/12/166of stay (LOS) for psychiatric inpatients either directly, by
increasing psychiatric symptoms or indirectly by
demanding the focus of medical attention during
hospitalization [10].
Longer admission, of course, means a greater financial
burden incurred. The last fifty years have been witness
to a significant change in mental health services delivery.
Attention has focused on using less and less inpatient
treatment, replacing hospital stay with treatment in the
community. In fact, longer hospital stay may nowadays
imply poor mental health care and support in the com-
munity. As a consequence, during the last two decades
there has been an increased interest by administrators
and governments responsible for financing mental health
services in reducing the money spent on inpatient ser-
vices and consequently in LOS reduction. Reduction of
LOS is associated with less expenditure and reducing
LOS is considered to be a sign of successful treatment in
the community.
Hospital stay has mostly been investigated with con-
secutively admitted inpatients irrespective of diagnosis
perhaps because early studies showed that diagnosis is
not associated with LOS [11,12] an issue which remains
controversial. Findings suggest that prediction of LOS is
far from straightforward given the complex nature of
LOS and the multiplicity of the factors involved [13-15].
Physical comorbidity is one aspect which has not been
investigated enough in reference to LOS. Comorbidity
can prove to be a nebulous concept and this has been a
complicating factor in the study of its effects. On the
one hand there are individuals who have a physical
problem (for instance hypertension) they are aware of
and receive treatment for and on the other, there are
individuals whose physical ailment is discovered during
the admission for treatment of another disorder. It isTable 2 Descriptive statistics and post-hoc tests across group
Number referrals Median Mean (S
Schizophrenia 0 referrals 14 16.46 (9.6
1 referral 18 21.52 (12
2 referrals 19.5 20.17 (8.5
3 referrals 27 29.78 (12
Bipolar 0 referrals 14 15.44 (7.6
1 referral 14.5 16.25 (8.4
2 referrals 19 23.17 (11
3 referrals 19 22.50 (10
Both groups 0 referrals (n = 208) 14 15.93 (8.6
1 referral (n = 146) 15 18.34 (10
2 referrals (n = 48) 19.5 21.67 (9.9
3 referrals (n = 26) 26 27.54 (12
Symbols a no referral vs. one referral b no referral vs. two referrals c no referral vs. t
Two-Sample Kolmogorov-Smirnov test.obvious that the latter patients require more attention
and need assessment and treatment for their physical ill-
ness urgently and effectively. The distinction between
serious ‘active’ medical comorbidity that receives med-
ical attention and ‘passive’ comorbidity was described by
Lyketsos et al. [10].
In this study we quantified the concept of active med-
ical comorbidity using referral as the criteria. The pri-
mary objective was to investigate whether and to what
extent the physical comorbidity that required medical at-
tention increased the LOS of inpatients with schizophre-
nia or bipolar disorder (type I or II). We measured
severe active comorbidity for which one, two, three or
more referrals were made to other specialties by the
attending psychiatrist. A passive comorbid condition
was one that after admission did not need referral to an-
other medical specialty for modification of treatment ei-
ther because it was existent and known to the patient
prior to admission or because it was discovered during
admission and was pharmacologically (or otherwise)
controlled by the attending psychiatrist. An active
comorbid condition was one that needed referral to a
medical specialty during hospitalization.
Our study had the following aims: 1) To explore
the prevalence and range of comorbid conditions for
which referral was needed in patients suffering from
schizophrenia and bipolar disorder. 2) To test the
hypothesis that severe comorbidity requiring referral
would affect length of stay in a linear fashion, in
both groups of patients 3) To investigate which fac-
tors, including referral, are associated with length of
stay across both diagnostic groups. 4) To investigate
whether referrals had an impact on patients’ ability
to function as measured by the scale General Assess-
ment of Functioning.s of referrals
D) U* Exact Sig. Z** Exact Sig.
15)
.136) 2230a 0.008a
35) 852b 0.013b 1.657b 0.002b
.804) 374c 0.000c 1.901c 0.000c
41)
12) 4614a 0.364a
.111) 756b 0.001b 1.559b 0.003b





hree or more referrals * U statistic of Mann Whitney test ** Z statistic of
Figure 1 The effect of referrals on GAF improvement for the
whole sample.
Table 3 Standard multiple linear regression: Individual predictors of hospital stay for schizophrenia and bipolar
patients
Unstandardized coefficients Stand coeff. t Sig. 95.0% CI for B
Model for schizophrenia B Std. error Beta Lower bound Upper bound
(Constant) 4.189 4.015 1.043 0.298 −3.73 12.108
Gender 5.824 1.482 0.258 3.930 0.001 2.900 8.747
On occupation or not during 6 months
prior to hospitalization
4.702 1.485 0.191 3.166 0.002 1.773 7.631
Substance misuse prior to hospitalization −14.665 3.209 −0.600 −4.57 0.001 −20.995 −8.335
The psychiatric comorbid status 16.956 3.414 0.687 4.966 0.001 10.222 23.691
Age of onset of mental disorder −0.314 0.058 −0.350 −5.418 0.001 −0.429 −0.200
BPRS 0.234 0.048 0.291 4.928 0.001 0.140 0.328
One ref vs. no ref 3.136 1.476 0.127 2.125 0.035 0.225 6.047
Three ref vs. no ref 17.343 2.404 0.444 7.215 0.01 12.601 22.085
Model for bipolar patients B Std. error Beta Lower bound Upper bound
(Constant) 17.295 1.303 13.275 0.001 14.727 19.862
Two ref vs. no ref 7.457 1.823 0.262 4.090 0.001 3.864 11.049
Single vs. married or divorced* 1.827 0.607 0.190 3.011 0.003 0.631 3.022
Distance from hospital** −3.239 1.354 −0.151 −2.393 0.018 −5.907 −0.571
Three ref vs. no ref 6.721 2.961 0.142 2.27 0.024 0.886 12.557
Symbols * binary variable ** binary variable: in Attica vs. Out of Attika.
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Schizophrenia group
We calculated the number of medical-surgical problems
for which patients with schizophrenia were referred to
other medical specialties AND subsequently received
treatment for, in absolute number and in terms of per-
centage of patients within the schizophrenia group. 100
patients (50%) had no referral for a comorbid condition
and 100 patients (50%) had one or more referrals. Of the
latter 58 patients (29% of patients with schizophrenia)
had one referral, 24 patients (12%) had two referrals and
18 patients (9%) had three or more referrals.
Table 1 shows the prevalence in % percentages of
ICD-10 categories as well as specific diagnoses of phys-
ical conditions which needed referral to specialists
across the schizophrenia group.
The median LOS for schizophrenia patients was
18 days (Mean 19.57 SD 11.227 N 200).
The Jonckheere Test was run to test for a linear asso-
ciation between number of referrals and LOS. All four
groups of patients were compared (no referral, one refer-
ral, two referrals, three or more referrals). The test
showed a significant linear trend in the data J= 8264,
z = 4.210, r = .29 p < .001 indicating that as the referrals
increased so did LOS. (Asymptotic 1-tailed sig. are
reported throughout the results section unless stated
otherwise).
Post-hoc Mann–Whitney tests were run to test for dif-
ferences in LOS between the three conditions (onereferral, two referrals, three or more referrals) and the
control group (no referral). A Bonferroni correction was
applied and the significance level was set at .0166.
Table 2 shows the results across groups for schizophre-
nia patients. Two-Sample Kolmogorov-Smirnov Tests
are also reported when any one of the subgroups had
small number of participants. There were statistically
significant differences between each of the three sub-
groups (one, two and three or more referrals) and the
control group (no referral).
Thus, overall, LOS was increased in all three cases
(one referral, two, three or more) and the more the
referrals the greater the increase in LOS.
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the model F [8] =14.561, p < .001). Results showed that
predictors account for .381 of the variation in LOS,
R = 0.62 R2 =0.381 Adjusted R2 = 0.355. All assumptions
were met. Table 3 shows the effects of individual contri-
butors on the outcome.
Bipolar group
As before, the number of medical problems for which
patients with bipolar disorder were referred were calcu-
lated in absolute number and in terms of percentage of
patients within the group. 108 patients (47, 4%) did not
need referral. 120 patients (52, 6%) needed one or more
referrals. Of these 88 patients (38, 6% within the bipolar
group) had one referral 24 patients (10, 5%) had two
referrals and only 8 patients 3, 5% had three or more
referrals.
Table 1 shows the prevalence in percentages of ICD-
10 categories and diagnoses of physical conditions which
needed referral to specialists across the bipolar group.
The median LOS for patients with bipolar disorder
was 15 days (Mean 16.82 SD 8.758 N 228), significantly
lower than the schizophrenia group U= 19828, p (2-
tailed) = .020 r =−.11.
The Jonckheere Test was run to test for a different ef-
fect of LOS among patients suffering from bipolar dis-
order (no referral, one referral, and two referrals, three
or more referrals). The test showed a significant positive
trend in the data J = 9410, z = 2.71, p = .003 r = .18.
Post-hoc Mann–Whitney tests were run to test for dif-
ferences in LOS between three conditions as in the
schizophrenia group. A Bonferroni correction was ap-
plied and the significance level was set at .0166. Again,
Two-Sample Kolmogorov-Smirnov Tests are also
reported. As shown in Table 2 only the patients with
two referrals had a statistically significant prolonged
LOS in comparison with the control group.
Thus, for bipolar patients the increase in LOS was
positively associated with increase in number of referrals
but only when two referrals were carried out, in this case
severe active comorbidity actually had a significant im-
pact on LOS.
A standard multiple regression for bipolar patients
gave a significant fit to the model F [4] =8.934 p < .001.
The variation in LOS, R = 0.372 R2 =0.138 Adjusted
R2 = 0.123. All assumptions were met. Table 3 shows the
effects of individual contributors on the outcome.
Both groups
Applied to the whole sample the Jonckheere Test again
showed a positive linear relationship between number of
referrals (four levels) and LOS J = 35782, z = 5.071
p < .001 r = .25. Table 2 shows statistics. The effect on
LOS was significant for patients with two referrals andpatients with three or more referrals (r =−.25 and r =−.3
respectively).
In addition, the overall effect of one or more referrals
on the level of functioning was investigated, patients
with no referral served as the control group. The
Mann–Whitney test (based on the binary variable
referral-non referral) was significant U= 19462, p (two
tailed) = .007 r =−.13 indicating that patients who were
referred to other specialties (n = 220) had a higher im-
provement in level of functioning as measured by GAF
(GAF discharge - GAF admission) than patients with no
active medical comorbidity (Figure 1).
Discussion
Comorbidity rates
In our study, 50% of the patients with schizophrenia and
52, 6% of patients with bipolar disorder needed referral
for a physical illness. This percentage is considerably
higher than the one reported by Lyketsos et al. where
medical comorbidity which merited medical attention
was present in 20.6% of the sample.
One in four inpatients with schizophrenia suffered
from an endocrine/metabolic disease with 12% of refer-
rals revealing Hashimoto’s thyroiditis. Patients suffering
from schizophrenia often present with high rates of
obesity, high blood pressure and diabetes, the so called
metabolic syndrome [16-18]. There are studies that link
endocrine disorders (including metabolic syndrome) to
the use of antipsychotics [19-21]. However, the finding
that 12% of the patients with schizophrenia were diag-
nosed with Hashimoto’s disease merits further attention
as this percentage is higher than that usually reported in
schizophrenia [22-24]. It has been argued that Hashimo-
tos disease can be a possible endophenotype of bipolar
disorder but to our knowledge, it has not been directly
associated with schizophrenia [25].
Length of stay of patients with schizophrenia
Most previous studies have studied inpatients with more
than two diagnoses and several relied exclusively on ad-
mission markers of LOS. Thus, the findings of this study
are not directly comparable with findings of earlier stud-
ies. Variability in designs, settings and samples further
complicates matters. However, some variables that are
common predictors of LOS are replicated here in the
schizophrenia group.
For patients with schizophrenia severe comorbidity had
a significant linear positive association with LOS. For all
three sub-groups of patients LOS was significantly pro-
longed: medians of 4, 5.5 and 13 days more for the three
groups (one ref, two refs, three or more ref) compared to
patients with no referral. The regression analysis verified
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et al. who discriminated between active and passive
comorbidity, but interestingly not in accordance with the
two studies which specifically focused on comorbidity and
LOS [26,27] and found that in patients with schizophrenia
comorbidity and LOS are not associated. Moreover,
although referral (three vs. no) had the most salient effect
in explaining the variance on LOS it appears that in this
group of patients both demographic and clinical variables
contribute substantially to increased stay. In concordance
with similar studies we found that gender [28,29] and
BPRS-E [30,31] account for differences in LOS. One
plausible explanation for the extended stay is that
patients suffering from schizophrenia do not receive
proper treatment in the community and both phys-
ical and psychiatric problems are not optimally
handled without submission to a general hospital
psychiatric department This consequently leads to
increased hospital stays and expenditure. This is
alarming and needs urgent attention since there are
indications that this is not unique to the Greek
health system [2].
Length of stay of patients with bipolar disorder
For patients with bipolar disorder, a positive significant
trend was found between referral-requiring comorbidity
and LOS. In comparison with the control group (no re-
ferral) no other group had a significant difference in
LOS except for the group with two referrals, a median of
5.5 days more. P values suggest that a bigger sample
might have been able to reach statistical significance for
the other groups as well. Regression also showed that se-
vere active comorbidity prolongs hospital stay. These
results are only partly in line with Sloan et al. [26] and
Schubert et al. [27] who found increased LOS for
depressed patients as no significant differences were
reported for not depressed bipolar patients. What is of
significance, here, is that only sociodemographic vari-
ables had an impact on LOS. This was an unexpected
and difficult-to-explain effect. Perhaps larger sample
sizes and other factors need to be studied regarding the
LOS of patients with bipolar disorder in order to be able
to reach safer results for patients with this diagnosis as
it is implausible that clinical factors such as severity of
the psychiatric condition do not have an effect on hos-
pital stay. In essence, the difference between the two
groups in the influence of severe comorbidity and LOS
can be seen as an indication that patients with bipolar
disorder may receive better physical care whilst living in-
dependently. This can be attributed to the nature of
their disorder (absence of negative symptoms etc.). Thus,
the results appear to confirm previous evidence that
negative symptoms can accurately predict LOS [30].Length of stay of the whole sample of patients
Analysis of the whole sample of inpatients showed that
the level of functioning improves more in psychiatric
inpatients with active comorbidity -when this is
addressed- than in patients without. This finding proves
the significance of meeting the needs of patients in
terms of general medical conditions. Longer admissions
one can argue, might lead to a greater reduction of psy-
chopathology, however the increased length of admis-
sion (maximum 10 days) is not long enough to support
the argument that pharmacotherapy is responsible for
this improvement.
Implications for health services
It is clear that provision of efficient community care for
patients with schizophrenia is an issue of priority as it
seems to prevent longer stays- and leads to better quality
of life [32].
Moreover, given the elevated active comorbidity for both
groups, the results confirm that general hospitals are a
better investment of the public money than psychiatric
units [32]; not least because when these patients are ad-
mitted to a psychiatric hospital or other inpatient psychi-
atric unit, their physical health needs are either not met or
if addressed lead to even longer admission and greater
cost. In the new era of short admissions our paper offers
support to the argument that there is an additional reason
for addressing quickly and effectively the medical pro-
blems of patients, since medical comorbidity resolution
may influence good psychiatric outcome. To this end close
cooperation between psychiatrists and medics is required
which should be promoted not only at a senior level but
also at the level of trainees and hospital interns [33]. Lon-
gitudinal research is needed in this respect in order to
have follow-up in terms of re-admissions for patients as
this might show that appropriate management of patients
with medical problems might prevent future admissions
and thus save health care resources in the long term.
Moreover, adequate screening of psychiatric patients for
medical problems may identify those at risk for admission
or readmission not only in a psychiatric but also in a med-
ical ward. This should also be the focus of future research.
To an extent research on LOS has been replaced by
research on determinants of health-care costs perhaps
because early studies, though important, were not suc-
cessful in identifying models that could account for a
large variance in LOS. However, recent studies [14,15]
[34,35] are more successful and are in accordance with
the results of this study in demonstrating how research
on this topic can provide very useful insights into the
management and improvement of psychiatric care of
patients in the health care system.
The different ways in which inpatient care is organized
in different contexts entails that the mean length of an
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be stated that Greece has not developed primary care
services. In this respect, some of the conditions resulting
in specialist referral are ones that in another country
one would normally expect to be managed in primary
care. On the other hand, the population studied was ad-
mitted to an inpatients psychiatric setting and thus refer-
ral to secondary or primary care would not be
applicable. The absence of further measures of psycho-
pathology on admission and discharge is a limitation of
this study. It is not expected that further standardised
test for psychopathology would add to the validity of our
findings. One cannot dismiss the possibility that detailed
psychopathological testing would be of particular signifi-
cance as it would permit us to investigate the effect of
comorbidity on functioning and also the relationship be-
tween aspects of psychiatric pathology and comorbidity
independent of LOS. Furthermore, since the physicians
were aware that these patients were suffering from a
psychiatric disorder one cannot altogether dismiss the
claim that prolongation of admission was to an extent a
result of a negative medical bias towards these patients
(examinations took longer to complete, reviews were not
as prompt as expected etc.).
Conclusions
Our findings confirm previous studies which found high
comorbidity among patients with bipolar disorder or
schizophrenia. However, in the present study the rates
were particularly elevated. Thus, an important aim of in-
patient care remains the prompt assessment of comorbid
physical illnesses of patients on admission, referral to
other medical specialties during hospitalization and dis-
charge of patients with specific guidelines and follow up
appointments for reassessment. Moreover, our results
offer concrete proof that lack of proper medical care for
patients with schizophrenia whilst living in the commu-
nity, is reflected in longer psychiatric stays. Although
this phenomenon is not unknown to psychiatrists and
other mental health professionals it remains unabated.




This was a naturalistic study conducted in the adult in-
patient psychiatric unit of the 2nd Psychiatry Depart-
ment of the Athens University Medical School, which is
based in Attikon General Hospital. Attikon Hospital
serves the western suburbs of Athens which are the
most densely populated area of the country. Data were
collected from the medical and nursing files of the
Department as well as the attending psychiatrists from
February 2009 to February 2011. Measures of the studyare detailed below. After the patients’ discharge we pro-
ceeded to analyze the data obtained. An inter-diagnosis
design was used, comparing LOS and the other para-
meters studied in patients with schizophrenia and physical
problems with patients with schizophrenia without
physical problems and patients with bipolar illness
and physical problems with bipolar patients without
physical problems. Data were analyzed using PASW,
version 18th.
Ethical approval for this research was granted by the
Attikon University General Hospital ethics Committee
and consequently by the Attikon General Hospital Sci-
entific Committee. Due to the sensitive nature of this
study in terms of both the information handled (access
to medical notes, data, records) and the apparent sever-
ity of the mental health conditions involved, the partici-
pants were briefed and provided consent both on
admission and after discharge. Shortly after admission
patients were orally informed of the general aims of the
study and were fully informed of their rights i.e. non-
participation, withdrawal at any stage without conse-
quences for their health care. In order not to unduly in-
fluence patients’ decisions to grant consent, a cooling off
period of two months after discharge was decided by the
researchers before each patient was re-approached to
provide full informed oral and written consent. Thus,
the sample presented here consists of the patients who
freely provided oral and written informed consent, both
on admission and after the cooling off period
aforementioned.
Participants
Participants were aged from 18 to 65. 180 of them had
Greek nationality and 36 were non-Greeks. 200 suffered
from schizophrenia (92 men and 108 women) and 228
from bipolar disorder (78 men and 150 women). Partici-
pants were either referred to the department inpatient
unit as emergencies by mental health professionals or
admitted via the emergency department of the hospital,
which is on call for psychiatric patients twice a week. All
patients were admitted voluntarily. No restraint,
enforced medication or seclusion was used during the
hospital admission of these patients.
Procedure
Every patient admitted to the unit received a full phys-
ical examination and blood tests as per the units admis-
sion protocol (the blood tests included FBC, urea and
electrolytes, cholesterol, liver and thyroid function test
as well as a urine drug screen). If the results from these
investigations pointed towards a problem then the ap-
propriate referral was made. If the patient consistently
complained of a somatic problem even without physical
evidence and the problem was not resolved following a
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a specialist referral was also made. The number and type
of referrals to other medical specialties was calculated by
asking the attending psychiatrist of each patient and
confirmed later by consulting the file of each patient.
Overall data were collected on: i) The sociodemo-
graphic characteristics of the patients on admission, ii)
functioning and psychiatric symptom severity on admis-
sion and upon discharge and iii) comorbidity and type
and number of referrals due to physical comorbidity on
or during admission.
More specifically: Sociodemographic characteristics
(age, sex, marital status, employment status during the
past six years and during the six months prior to admis-
sion, urban or rural residence status). Psychiatric dis-
order characteristics (diagnosis, age of onset, number of
prior hospitalizations, psychiatric comorbidity and sub-
stance misuse prior to admission).
Comorbidity requiring referral was a yes/no variable.
As explained above, if a patient was referred to another
medical specialty he would score a ‘yes’ answer. If the
consulting specialist did not, on admission or during
hospitalization, diagnose a medical problem that needed
treatment, then the patient would score a ‘no’ answer.
Thus, in the ‘no’ category we had patients 1) without
concurrent medical condition or 2) without concurrent
medical condition that needed further treatment. In the
‘yes’ category we had patients who had been diagnosed
with a medical problem by the consulting specialist and
received treatment for it.
We also noted the number and type of referrals to
other medical specialties per patient in order to assess
the prevalence of medical-surgical conditions that
needed treatment in patients admitted with the diagnosis
of either schizophrenia or bipolar disorder.
Classification of physical conditions was according to
ICD-10 [36]. Thirteen broad categories of ICD-10 were
used for an initial classification of the medical problems
that the patient was referred for. Whenever the phys-
ician did not provide a diagnosis, then the patient would
be categorized as not in need of medical intervention
from the specialty he/she was referred to. If a patient
was referred to the same medical speciality for more
than one reason on the same referral, this would still
count as one referral (this happened only on 3 occasions
1 male with schizophrenia and 2 patients with bipolar
disorder (1 m, 1 f ). We then re-categorized for specific
physical conditions within the most commonly reported
categories of our first categorization.
The social and psychological functioning of patients
on admission and discharge was assessed by the Global
Assessment of Functioning (GAF) scale. GAF is widely
used in psychiatric practice and is the AXIS V of the
DSM- IV-TR [37,38], it is easy to complete and hasestablished good validity [39-41]. For the schizophrenia
group we used one more scale: The Brief Psychiatric
Rating Scale- Extended version (BPRS-E) [42] was used
to assess symptom severity on admission for patients
with schizophrenia. The BPRS-E is a psychometric in-
strument which comprises 24 symptom constructs, each
rated in a 7-point scale of severity; it has been used ex-
tensively with patients with severe and persistent mental
problems and has established good reliability and validity
[43]. In addition, the BPRS-E total score has been a good
predictor of LOS in patients with severe mental illness
[30]. Finally, the Hamilton depression rating scale
(HDRS) one of the most widely used scales for depres-
sion, with good reliability [44,45] and validity [46,47]
[48] was used for the patients with bipolar disorder.
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